Free Trial

Adverum Biotechnologies (ADVM) SEC Filings & 10K Form

Adverum Biotechnologies logo
$6.17 -0.08 (-1.28%)
(As of 11/20/2024 ET)

Recent Adverum Biotechnologies SEC Filings

DateFilerForm TypeView
11/14/2024
5:40 PM
Adverum Biotechnologies (Subject)
Logos Global Management LP (Filed by)
Form SC 13G/A
11/14/2024
5:57 PM
Adverum Biotechnologies (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13G/A
11/06/2024
4:49 PM
Adverum Biotechnologies (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
11/04/2024
3:42 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
3:44 PM
Adverum Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
11:41 AM
Adverum Biotechnologies (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G
10/30/2024
8:34 PM
Adverum Biotechnologies (Subject)
Stern Augustus (Filed by)
Form SC 13G
10/23/2024
12:34 PM
Adverum Biotechnologies (Subject)
Principia Wealth Advisory, LLC (Filed by)
Form SC 13G
10/22/2024
5:06 PM
Adverum Biotechnologies (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
08/12/2024
3:08 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
3:10 PM
Adverum Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/22/2024
3:24 PM
Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
Form SC 13G/A
07/18/2024
8:16 PM
Adverum Biotechnologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:16 PM
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:16 PM
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/17/2024
3:38 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
3:47 PM
Adverum Biotechnologies (Issuer)
Svoronos Dawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:48 PM
Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:48 PM
Adverum Biotechnologies (Issuer)
Hong Soo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:49 PM
Adverum Biotechnologies (Issuer)
Nicholson, C. David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:50 PM
Adverum Biotechnologies (Issuer)
Ozden Rabia Gurses (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:42 PM
Adverum Biotechnologies (Issuer)
Kiss Szilard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2024
3:43 PM
Adverum Biotechnologies (Issuer)
Kiss Szilard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:43 PM
Adverum Biotechnologies (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:44 PM
Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:45 PM
Adverum Biotechnologies (Issuer)
Whitcup Scott M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:46 PM
Adverum Biotechnologies (Issuer)
Tuckson Reed Vaughn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:10 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2024
11:15 PM
Adverum Biotechnologies (Filer)
Form EFFECT
03/26/2024
11:15 PM
Adverum Biotechnologies (Filer)
Form EFFECT
03/21/2024
4:24 PM
Adverum Biotechnologies (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/20/2024
4:04 PM
Adverum Biotechnologies (Filer)
Form 424B3
03/20/2024
3:13 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
6:05 PM
Adverum Biotechnologies (Issuer)
Fischer Laurent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:06 PM
Adverum Biotechnologies (Issuer)
Soparkar Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:07 PM
Adverum Biotechnologies (Issuer)
Seyedkazemi Setareh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:40 PM
Adverum Biotechnologies (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/22/2024
2:47 PM
Adverum Biotechnologies (Subject)
Adverum Biotechnologies (Subject)
Logos Global Management LP (Filed by)
Logos Global Management LP (Filed by)
Form SC 13G
02/21/2024
2:39 PM
Adverum Biotechnologies (Filer)
Form D
Notice of Exempt Offering of Securities 
02/15/2024
3:17 PM
Adverum Biotechnologies (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
02/14/2024
7:26 PM
Adverum Biotechnologies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
Trump said you could learn something from this man (Ad)

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.
02/13/2024
6:34 PM
Adverum Biotechnologies (Subject)
BANK OF AMERICA CORP /DE/ (Filed by)
Form SC 13G/A
02/12/2024
9:13 AM
Adverum Biotechnologies (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
02/09/2024
4:50 PM
Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
4:51 PM
Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:35 AM
Adverum Biotechnologies (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/08/2024
7:45 AM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
10:36 AM
Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
Form SC 13G/A
02/06/2024
3:47 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ADVM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners